Isner, J M <br/><br/>
Assessment of risks associated with cardiovascular gene therapy in human subjects.  [electronic resource] 

 -  Circulation research  Aug 2001 
 - 389-400 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>1524-4571 
<br/><br/><label>Standard No.: </label>10.1161/hh1701.096259  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases--genetics<br/>Clinical Trials as Topic--statistics & numerical data<br/>Endothelial Growth Factors--genetics<br/>Genetic Therapy<br/>Genetic Vectors--genetics<br/>Humans<br/>Lymphokines--genetics<br/>Risk Assessment<br/>Risk Factors<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors